SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-51.11%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Total debt
Total debt on the balance sheet as of December 2023 : $15.08 M
According to SCYNEXIS's latest financial reports the company's total debt is $15.08 M. A company’s total debt is the sum of all current and non-current debts.
SCYNEXIS - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $48.59 M | 11.39% |
| 2021-12-31 | $43.62 M | 119.87% |
| 2020-12-31 | $19.84 M | 33.31% |
| 2019-12-31 | $14.88 M | -1.31% |
| 2018-12-31 | $15.08 M | 2.93% |
| 2017-12-31 | $14.65 M | 2.81% |
| 2016-12-31 | $14.25 M | |
| 2013-12-31 | $15 M | -43.28% |
| 2012-12-31 | $26.44 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $0.04 M | -99.73% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $3.55 M | -76.41% | 🇺🇸 USA |
 Catalent CTLT | $5.01 B | 33,149.34% | 🇺🇸 USA |
 KemPharm KMPH | $23.11 M | 53.30% | 🇺🇸 USA |